Particle News: Latest European Medicines Agency news

6 ARTICLES

2d ago

Health Agencies Rebut Trump’s Tylenol–Autism Claim as Calls Grow for Clear Guidance

Health leaders urge clear guidance to prevent needless alarm among pregnant patients.

26 ARTICLES

4d ago

WHO, EMA and Pediatric Societies Rebuke Trump’s Claim That Prenatal Tylenol Causes Autism

126 ARTICLES

5d ago

Officials, Doctors Rebuke White House Warning Tying Prenatal Tylenol to Autism

381 ARTICLES

6d ago

Global Regulators Reject Trump’s Tylenol–Autism Claim as U.S. Issues Pregnancy Advisories

101 ARTICLES

last wk.

Trump Urges Pregnant Women to Avoid Tylenol, Drawing Rapid Pushback From Health Authorities

3 ARTICLES

last wk.

GLP-1 Agonists Linked to Small Rise in Diabetic Retinopathy and Rare Optic-Nerve Events

5 ARTICLES

last mo.

FDA Lifts Pause on Valneva’s Chikungunya Vaccine for Seniors

15 ARTICLES

2mo ago

Regulators Halt Elevidys Gene Therapy Worldwide After Safety Failures

Particle.news

European Medicines Agency

Government agency

Health Agencies Rebut Trump’s Tylenol–Autism Claim as Calls Grow for Clear Guidance

WHO, EMA and Pediatric Societies Rebuke Trump’s Claim That Prenatal Tylenol Causes Autism

Officials, Doctors Rebuke White House Warning Tying Prenatal Tylenol to Autism

Global Regulators Reject Trump’s Tylenol–Autism Claim as U.S. Issues Pregnancy Advisories

Trump Urges Pregnant Women to Avoid Tylenol, Drawing Rapid Pushback From Health Authorities

EU Panel Backs Tezspire for Chronic Rhinosinusitis With Nasal Polyps

EU Regulators Back Uplizna as First Treatment for IgG4‑Related Disease

CHMP Backs Subcutaneous Lunsumio for Relapsed Follicular Lymphoma

Roche to Acquire 89bio in Deal Worth Up to $3.5 Billion

EMA Approves Cardiovascular Indication for Novo Nordisk’s Rybelsus

Never miss stories about

European Medicines Agency

EMA Opens Safety Review of Levamisole Over Reported Brain Injury Risk

U.S. to Buy Lenacapavir PrEP Doses to Reach Up to 2 Million People by 2028

Mexico Clears Updated COVID-19 Vaccines Targeting LP.8.1 for 2025–26 Season

EMA Flags Very Rare Vision-Loss Risk for Ozempic and Wegovy

European Commission Approves Ogsiveo as First Therapy for Desmoid Tumors

EU Mandates New Warning on Systemic Diclofenac Skin Reaction

JAMA Studies Find Rare Optic-Nerve Risks With Semaglutide and Tirzepatide

GLP-1 Agonists Linked to Small Rise in Diabetic Retinopathy and Rare Optic-Nerve Events

FDA Lifts Pause on Valneva’s Chikungunya Vaccine for Seniors

Regulators Halt Elevidys Gene Therapy Worldwide After Safety Failures

Never miss stories about

European Medicines Agency